Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
09:21am | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
05-01 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 4M | |
-1.27% | 4.36B | |
-13.09% | 3.29B | |
+7.38% | 1.59B | |
+34.87% | 1.22B | |
+82.85% | 881M | |
+35.07% | 873M | |
+15.29% | 582M | |
-24.06% | 561M | |
-.--% | 154M |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.
- BTIG Adjusts Price Target on Cullinan Oncology to $30 From $20, Maintains Buy Rating